Gabe is a litigator and eDiscovery specialist with more than a decade of experience defending pharmaceutical and medical device companies in complex litigation. In these roles, Gabe provides creative and insightful counsel regarding the challenges posed by an ever-changing discovery landscape and exponential data growth.

eDiscovery

As a member of Shook’s Data and Discovery Strategies group, Gabe advises clients on a range of discovery-related issues related to preservation, collection, processing, and review of documents for production and case assessment. He strives to provide effective and efficient strategies for addressing the asymmetric discovery often faced by defendants in product liability mass torts. Gabe defends clients in various discovery disputes. He also manages document reviews and has extensive experience preparing protective orders, document production protocols and other discovery-related materials.

Litigation

Gabe focuses his practice on product liability litigation for companies that develop and manufacture lifesaving and life-improving medicines and medical devices. He also has experience litigating other complex matters, including False Claims Act and commercial warranty actions. Over the course of his career, Gabe has worked on multidistrict litigation and numerous individual matters in state and federal courts across the country for clients including Bayer, Boston Scientific, Covidien, Genentech, Medtronic, Stryker and Takeda. Gabe has participated in all phases of litigation ranging from fact and expert discovery to dispositive motion practice, trial and appeal. He routinely briefs complex legal issues such as federal preemption of claims against FDA-approved medical devices.

Representative Matters

In re: Genentech Herceptin (Trastuzumab) Marketing and Sales Practices Litigation, MDL 2700

Essure Product Cases, California Judicial Council Coordinated Proceeding 4887 (and related cases)

In re: Zantac (Ranitidine) Product Liability Litigation, MDL 2924 (and related cases)

Presentations and Publications 

Panelist, Too Much Is Never Enough: Defining the Number of Custodians & Other Sources Under 26(b)1 & State Corollaries, Electronic Discovery Institute Leadership Summit, Santa Barbara, October 14, 2021.

Panelist, Understanding the Use of Data Analytics in the Management of MDLs, Drug and Medical Device Litigation Virtual Conference, American Conference Institute (ACI), New York City, December 9, 2020. 

Presenter, Navigating the ESI Crisis When Your Adversaries Target Information Governance Practices, Association of Corporate Counsel Annual Meeting, Phoenix, October 28, 2019 (with Jennifer Hamilton, David Steele and Jennifer Swanton). 

Harvey L. Kaplan, Mark W. Cowing & Gabriel P. Egli, A Primer for Data-Protection Principles in the European Union, Culture Clash! Data Protection, Freedom of Information and Discovery – How to Protect Your Business in Transnational Disputes, Defense Research Institute (DRI) Europe (Munich, Germany), May 2009.

Gabriel Egli, Don't Get BIT: Addressing ICSID's Inconsistent Application of Most-Favored-Nation Clauses to Dispute Resolution Provisions, Pepperdine Law Review 34 (4), May 2007.